Doktorsavhandlingar
Anish Behere (2022)
Ex‘PLA’ining the progression of pathological proteins in Alzheimer’s and Parkinson’s diseases: see(d)ing is believing.
Evangelos Konstantinidis (2022)
CRISPR/Cas9-based therapies and the role of astrocytes in Alzheimer’s disease and Parkinson’s disease.
Tobias Gustavsson (2022)
Brain distribution of a bispecific antibody targeting Aβ.
Hanna Bozkurt Åhman (2021)
Timed Up-and-Go Dual-Task Tests for Early Detection of Dementia Disorder.
María Pagnon de la Vega (2021)
Characterization of the novel “Uppsala mutation” causing a familial form of early onset Alzheimer’s disease.
Silvio R. Meier (2021)
Preclinical PET imaging and therapy of Alzheimer's disease.
Jinar Rostami (2020)
The role of glial cells in alpha-synuclein pathology: Focus on degradation, cell-to-cell propagation and inflammation.
Kristin Franzon (2019)
Independent Ageing in Very Old Swedish Men.
Leire Almandoz Gil (2018)
Characterization of Physiological and Pathological Alpha-Synuclein: Implications for Parkinson’s Disease and Related Disorders.
Elisabeth Nikitidou (2018)
Cellular responses to amyloid-beta protofibrils: Focus on astrocytes, extracellular vesicles and antibody treatment.
Xiaotian T. Fang (2018)
Preclinical PET imaging of Alzheimer's disease progression.
Gabriel Gustafsson (2017)
Alpha-Synuclein Oligomers: Cellular Mechanisms and Aspects of Antibody Treatment.
Sofia Söllvander (2015)
Amyloid-β Protofibrils in Alzheimer´s Disease: Focus on Antibodies, Inflammation and Astrocytes.
Elisabeth Jobs (2014)
Cathepsin S as a Biomarker of Low-grade Inflammation, Insulin Resistance, and Cardiometabolic Disease Risk.
Ylva Cedervall (2014)
Physical Activity and Alzheimer's Disease: Measurements, Observations and Subjective Experiences.
Astrid Gumucio (2014)
Therapeutic and functional studies in animal models of Alzheimer's disease.
Elisabet Nerpin (2013)
The Kidney in Different Stages of the Cardiovascular Continuum.
Therese Fagerqvist (2013)
Studies of α-synuclein Oligomers-with Relevance to Lewy Body Disorders.
Malin Degerman Gunnarsson (2013)
Biomarkers as Monitors of Drug Effect, Diagnostic Tools and Predictors of Deterioration Rate in Alzheimer's Disease.
Elina Rönnemaa (2012)
Predictors of Dementia: Insulin, Fatty Acids and Vascular Risk Factors.
Thomas Näsström (2011)
Characterization of α-synuclein oligomers: Implications for Lewy Body Disorders.
Paul O'Callaghan (2011)
Heparan Sulfate in the Amyloidosis and Inflammation of Alzheimer’s Disease.
Johan Sundelöf (2010)
Amyloid ß-protein, Cystatin C and Cathepsin B as Biomarkers of Alzheimer's Disease.
Dag Sehlin (2010)
Aß Conformation Dependent Antibodies and Alzheimer's Disease.
Ola Philipson (2010)
Modeling Amyloid-ß Pathology in Alzheimer's Disease Using the Arctic Mutation.
Bernice Wiberg (2010)
Risk Factors for Stroke in Adult Men: A Population-based Study.
Hans-Erik Johansson (2010)
The Impact of Bariatric Surgery on Obesity related Metabolic Traits with Specific Emphasis on Glucose, Insulin and Proinsulin.
Lars Berglund (2009)
Measurement Variability Related to Insulin Secretion and Sensitivity: Assessment and Implications in Epidemiological Studies.
Hillevi Englund (2009)
Soluble amyloid-ß aggregates in Alzheimer's disease.
Anna Lord (2009)
Targeting Early Stages of Alzheimer's Disease in a Transgenic Model.
Lena Skoglund (2009)
Molecular Mechanisms of Frontotemporal Lobar Degeneration.
Elin Blom (2008)
Genetic Studies of Alzheimer's Disease.
Ann-Sofi Johansson (2007)
Amyloid beta Protofibril Formation and Neurotoxicity: Implications for Alzheimer's Disease.
Charlotte Sahlin (2007)
Pathogenic Mechanisms of the Arctic Alzheimer Mutation.
Erik Ingelsson (2005)
Insulin Resistance and Inflammation as Risk Factors for Congestive Heart Failure.
Kristina Dunder (2004)
Clinical Manifestations of Coronary Heart Disease and the Metabolic Syndrome: A Population-based Study in Middle-aged Men in Uppsala.
Anna Cristina Åberg (2003)
General Motor Function Assessment and Perceptions of Life Satisfaction during and after Geriatric Rehabilitation.
Björn Zethelius (2002)
Proinsulin and Insulin Sensitivity as Predictors of Type 2 Diabetes Mellitus and Coronary Heart Disease: Clinical Epidemiological Studies with up to 27 Years of Follow-Up.
Johan Ärnlöv (2002)
Left Ventricular Function in Elderly Men: Metabolic, Hormonal, Genetic and Prognostic Implications.
Kristina Björklund (2002)
24-hour Ambulatory Blood Pressure - Relation to the Insulin Resistance Syndrome and Cardiovascular Disease.
Liisa Byberg (2002)
Plasminogen Activator Inhibitor-1 and the Insulin Resistance Syndrome.
Arvo Hänni (2001)
Magnesium and the Insulin Resistance Syndrome.
Anu Hedman (2001)
Muscle Morphology and the Insulin Resistance Syndrome: A Population-Based Study of 70 Year-Old-Men in Uppsala.
Johan Sundström (2001)
Left ventricular hypertrophy and the insulin resistance syndrome.